Improving Human Health Through Innovation

ApoPharma is an innovative drug company devoted to providing drug products that help improve the quality of life of patients with debilitating and life-threatening diseases.

Our strength is that we are a small group, dedicated to helping patient populations who rely on our prescription medicines for improved quality of life.

We are engaged in the discovery and development of new molecules to treat conditions where there are unmet medical needs.

Our strategic focus lies in 3 key areas:

  1. hematological conditions where iron overload plays a role;
  2. neurodegenerative diseases; and,
  3. immune-related conditions.

Our management team combines deep scientific knowledge with proven drug development and marketing acumen. This provides ApoPharma’s innovative drive to supply patients with much needed medicines that address hard-to-treat, and often rare disorders.

Our senior level management team consists of:

Michael Spino, Pharm. D., B.Sc. Phm.


Fernando Tricta, M.D., M.Sc.

Vice President of Medical Affairs

Michael Woolcock, B.Sc.

Vice President of Sales & Marketing


John Connelly

Vice President of Regulatory Affairs and Non-Clinical Research

For more detail on the senior management team, click here


You are now leaving ApoPharma Inc. This link will take you to a web site where this site’s Privacy Policy does not apply. You are solely responsible for your interactions with that web site. We encourage you to read the privacy policy of every Web site you visit.



You have expressed an interest in looking at job openings for ApoPharma Inc. You are now leaving the ApoPharma website and entering the Apotex website. Do not be concerned, ApoPharma is a part of the Apotex group of companies. All job openings for Apotex member companies, including those for ApoPharma Inc. are found on this website.